PCN79 Pharmacoeconomic Evaluation of Acute Myeloid Leukemia and MDS Syndromes (Intermediate and High Risk) Treatment With Azacitidine in the Russian Federation
Nov 1, 2012, 00:00 AM
10.1016/j.jval.2012.08.2119
https://www.valueinhealthjournal.com/article/S1098-3015(12)03833-8/fulltext
Section Title :
Cancer
Section Order :
772
First Page :
A423
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03833-8&doi=10.1016/j.jval.2012.08.2119